A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Calcium chloride
Berotralstat
The metabolism of Dapagliflozin can be decreased when combined with Berotralstat.
Calcium chloride
Lorcaserin
The metabolism of Dapagliflozin can be decreased when combined with Lorcaserin.
Calcium chloride
Mirabegron
The metabolism of Dapagliflozin can be decreased when combined with Mirabegron.
Calcium chloride
Rhein
The metabolism of Dapagliflozin can be decreased when combined with Rhein.
Calcium chloride
Dosulepin
The metabolism of Dosulepin can be decreased when combined with Dapagliflozin.
Calcium chloride
Lumefantrine
The metabolism of Dapagliflozin can be decreased when combined with Lumefantrine.
Calcium chloride
Ritanserin
The metabolism of Dapagliflozin can be decreased when combined with Ritanserin.
Calcium chloride
Asunaprevir
The metabolism of Dapagliflozin can be decreased when combined with Asunaprevir.
Calcium chloride
Phenylbutyric acid
The metabolism of Dapagliflozin can be decreased when combined with Phenylbutyric acid.
Calcium chloride
Vilazodone
The metabolism of Dapagliflozin can be decreased when combined with Vilazodone.
Calcium chloride
Panobinostat
The metabolism of Dapagliflozin can be decreased when combined with Panobinostat.
Calcium chloride
Manidipine
The metabolism of Dapagliflozin can be decreased when combined with Manidipine.
Calcium chloride
Sulfaphenazole
The metabolism of Dapagliflozin can be decreased when combined with Sulfaphenazole.
Calcium chloride
Rucaparib
The metabolism of Dapagliflozin can be decreased when combined with Rucaparib.
Calcium chloride
Rolapitant
The metabolism of Dapagliflozin can be decreased when combined with Rolapitant.
Calcium chloride
Osilodrostat
The metabolism of Dapagliflozin can be decreased when combined with Osilodrostat.
Calcium chloride
Aliskiren
The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Aliskiren.
Calcium chloride
Riociguat
The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Riociguat.
Calcium chloride
Moxonidine
The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Moxonidine.
Calcium chloride
Indoramin
The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Indoramin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3